Eternity Insights has published a new study on Global Gene Therapy Market focusing on key segments as by Type (Ex Vivo, In Vivo, Other), by Application (Cancer Diseases, Hematological Disease, Hereditary Disease, Others), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Gene Therapy Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Gene Therapy Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Gene Therapy market in terms of demand generation. The Gene Therapy market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Gene Therapy market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
To learn more about this report
The global Gene Therapy market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
Report Attributes | Details |
The market size value in 2021 | USD XX.XX Million |
CAGR (2021 - 2028) | XX.XX % |
The Revenue forecast in 2028 | USD XX.XX Million |
Base year for estimation | 2021 |
Historical data | 2018-2019 |
Forecast period | 2022-2028 |
Quantitative units |
|
Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
By Type Outlook | Ex Vivo, In Vivo, Other |
By Application Outlook | Cancer Diseases, Hematological Disease, Hereditary Disease, Others |
Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
Key companies profiled | Kite Pharma, BioVex, Novartis, Spark Therapeutics |
Customization Available | Yes, the report can be tailored to meet your specific requirements. |
Table of Contents
Gene Therapy Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Gene Therapy
1.1 Gene Therapy Market Overview
1.1.1 Gene Therapy Product Scope
1.1.2 Market Status and Outlook
1.2 Global Gene Therapy Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Gene Therapy Market by Type
1.3.1 Ex Vivo
1.3.2 In Vivo
1.4 Gene Therapy Market by End Users/Application
1.4.1 Cancer Diseases
1.4.2 Hematological Disease
1.4.3 Hereditary Disease
1.4.4 Others
2 Global Gene Therapy Competition Analysis by Players
2.1 Gene Therapy Market Size (Value) by Players (2018 and 2019)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Kite Pharma
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Gene Therapy Revenue (Value) (2014-2019)
3.1.5 Recent Developments
3.2 BioVex
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Gene Therapy Revenue (Value) (2014-2019)
3.2.5 Recent Developments
3.3 Novartis
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Gene Therapy Revenue (Value) (2014-2019)
3.3.5 Recent Developments
3.4 Spark Therapeutics
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Gene Therapy Revenue (Value) (2014-2019)
3.4.5 Recent Developments
4 Global Gene Therapy Market Size by Type and Application (2014-2019)
4.1 Global Gene Therapy Market Size by Type (2014-2019)
4.2 Global Gene Therapy Market Size by Application (2014-2019)
4.3 Potential Application of Gene Therapy in Future
4.4 Top Consumer/End Users of Gene Therapy
5 North America Gene Therapy Development Status and Outlook
5.1 North America Gene Therapy Market Size (2014-2019)
5.2 North America Gene Therapy Market Size and Market Share by Players (2018 and 2019)
6 Europe Gene Therapy Development Status and Outlook
6.1 Europe Gene Therapy Market Size (2014-2019)
6.2 Europe Gene Therapy Market Size and Market Share by Players (2018 and 2019)
7 China Gene Therapy Development Status and Outlook
7.1 China Gene Therapy Market Size (2014-2019)
7.2 China Gene Therapy Market Size and Market Share by Players (2018 and 2019)
8 Rest of Asia Pacific Gene Therapy Development Status and Outlook
8.1 Rest of Asia Pacific Gene Therapy Market Size (2014-2019)
8.2 Rest of Asia Pacific Gene Therapy Market Size and Market Share by Players (2018 and 2019)
9 Central & South America Gene Therapy Development Status and Outlook
9.1 Central & South America Gene Therapy Market Size (2014-2019)
9.2 Central & South America Gene Therapy Market Size and Market Share by Players (2018 and 2019)
10 Middle East & Africa Gene Therapy Development Status and Outlook
10.1 Middle East & Africa Gene Therapy Market Size (2014-2019)
10.2 Middle East & Africa Gene Therapy Market Size and Market Share by Players (2018 and 2019)
11 Market Forecast by Regions, Type and Application (2019-2025)
11.1 Global Gene Therapy Market Size (Value) by Regions (2019-2025)
11.1.1 North America Gene Therapy Revenue and Growth Rate (2019-2025)
11.1.2 Europe Gene Therapy Revenue and Growth Rate (2019-2025)
11.1.3 China Gene Therapy Revenue and Growth Rate (2019-2025)
11.1.4 Rest of Asia Pacific Gene Therapy Revenue and Growth Rate (2019-2025)
11.1.5 Central & South America Gene Therapy Revenue and Growth Rate (2019-2025)
11.1.6 Middle East & Africa Gene Therapy Revenue and Growth Rate (2019-2025)
11.2 Global Gene Therapy Market Size (Value) by Type (2019-2025)
11.3 Global Gene Therapy Market Size by Application (2019-2025)
12 Gene Therapy Market Dynamics
12.1 Gene Therapy Market Opportunities
12.2 Gene Therapy Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Gene Therapy Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Gene Therapy Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
Choose License Type